News Shanghai RAAS Blood Products Co., Ltd.

Equities

002252

CNE100000C31

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
7.44 ^CNY	-1.06%		+3.62%	-7.00%

Apr. 29	Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	RAAS Blood Products' 2023 Profit Falls 5% Despite 21% Revenue Growth	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
RAAS Blood Products' 2023 Profit Falls 5% Despite 21% Revenue Growth	Apr. 29	MT
Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 28	CI
Grifols to refinance debt due in 2025 via sales of notes, Shanghai RAAS stake	Apr. 10	RE
RAAS Blood Products Gets Regulatory Nod to Trial Drug for Bleeding Disorders	Mar. 05	MT
Grifols says due diligence was carried out on Shanghai RAAS stake sale	Mar. 01	RE
Grifols' shares tumble as restructuring costs hit annual profit	Feb. 29	RE
S&P Maintains Grifols' Rating, Stable Outlook Amid Expected Deleveraging	Jan. 22	MT
S&P keeps Grifols at 'B+', sees leverage decreasing in 2024	Jan. 19	RE
ECB probes banks over exposure to Spanish drugmaker Grifols: sources	Jan. 17	RE
ECB sounds out lenders on exposure to Spanish drugmaker Grifols - sources	Jan. 17	RE
The Ibex-35 rebounds without leaving the range of the last month and a half.	Jan. 15	RE
Grifols Wins Assurance from Haier for Shanghai RAAS Stake Deal	Jan. 15	MT
Grifols says Haier Group still OK to buy stake in Shanghai RAAS	Jan. 14	RE
GRIFOLS: HAIER GROUP'S CHAIRWOMAN SAYS COMPANY CONTINUES TO WOR…	Jan. 14	RE
Grifols shares suffer worst week on record after short-seller report	Jan. 12	RE
Grifols foresees no problems in the sale of its stake in China despite Gotham City's report	Jan. 12	RE
Grifols to Finalize $1.8 Billion Shanghai RAAS Stake Sale as Planned in H1	Jan. 12	MT
Grifols sees no impact from Gotham report on China stake sale	Jan. 11	RE
GRIFOLS VICE CHAIR: WE SEE NO PROBLEM IN CLOSING SALE OF SHANGHA…	Jan. 11	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shanghai RAAS Blood Products Co., Ltd.

Equities

002252

CNE100000C31

Summary

Filters